IL6 and major depressive disorder: Overall, these findings indicate that knocking down IL‐6 in hippocampal microglia and IL‐6R in hippocampal astrocytes, along with inhibition of the IL‐6 trans‐signaling pathway using sgp130, significantly alleviates depression‐like behaviors and reduces astrocyte atrophy in CSDS mice.